Quote:
Originally Posted by Tobra
Tadd, that is fairly typical in studies such as this.
From what I read, the remedsivir group vs placebo were 8% fatality vs 11%, or something like that.
I wonder if that is statistically significant.
|
The mortality benefit was not quite stat sig, something like p = 0.058.
The shorter hospitalization benefit was definitely stat sig.